EWTX20260220C19
EWTX Feb 20 2026 19.00 Call (EWTX260220C00019000)
option OPRA

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.